会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 73. 发明授权
    • Nitrogen-containing heterocyclic compounds
    • 含氮杂环化合物
    • US4752414A
    • 1988-06-21
    • US884349
    • 1986-07-11
    • Rudolf EidenschinkJoachim KrauseReinhard HittichEike PoetschBernhard ScheubleGeorg WeberLudwig Pohl
    • Rudolf EidenschinkJoachim KrauseReinhard HittichEike PoetschBernhard ScheubleGeorg WeberLudwig Pohl
    • C07D239/26C07D239/28C07D239/30C07D239/34C07D239/54C09K19/34C09K19/46G02F1/13C07D239/55C07D239/36C09K19/42
    • C07D239/26C07D239/34C09K19/3441
    • Nitrogen-containing heterocyclic compounds of the formula IR.sup.1 --A.sup.1 --Z.sup.1 --A.sup.2 --[Z.sup.2 --A.sup.3 ].sub.n --R.sup.2whereinR.sup.1 and R.sup.2 in each case independently of one another are an alkyl group with 1-15 C atoms, it also being possible for one or two non-adjacent CH.sub.2 groups to be replaced by O atoms and/or --CO-- groups and/or --O--CO-- groups and/or --CO--O-- groups, and one of the radicals R.sup.1 and R.sup.2 is also H, F, Cl, Br or CN,A.sup.1 is a 1,4-cyclohexylene group, it also being possible for one or two non-adjacent CH.sub.2 groups to be replaced by O atoms, a 1,4-bicyclo-(2,2,2)-octylene group or a 1,3-dithiane-2,5-diyl group,Z.sup.1 and Z.sup.2 in each case independently of one another are --CO--O--, --O--CO--, --CH.sub.2 CH.sub.2 --, --OCH.sub.2 --, --CH.sub.2 O-- or a single bond,A.sup.2 and A.sup.3 in each case independently of one another are a 1,4-phenylene group, pyrimidine-2,5-diyl group, 1,4-cyclohexylene group, it also being possible for one or two non-adjacent CH.sub.2 groups to be replaced by O atoms, 1,3-dithiane-2,5-diyl group or a 1,4-bicyclo(2,2,2)-octylene group andn is 0 or 1,with the provisos that(a) at least one of the groups A.sup.2 and A.sup.3 is a pyrimidine-2,5-diyl group,(b) at least one of the groups Z.sup.1 and Z.sup.2 is not a single bond if A.sup.2 is pyrimidine-2,5-diyl and R.sup.2 is alkyl or CN,(c) Z.sup.1 is not --CO--O-- if A.sup.3 is pyrimidine-2,5-diyl and A.sup.1 is 1,4-cyclohexylene,(d) n is not 0 if A.sup.1 is 1,4-cyclohexylene and Z.sup.1 is --CH.sub.2 CH.sub.2 --, and(e) Z.sup.1 is not --CH.sub.2 CH.sub.2 -- if R.sup.2 is CN, and(f) Z.sup.1 is --CH.sub.2 CH.sub.2 --, --OCH.sub.2 -- or --CH.sub.2 O--, if A.sup.1 is 1,4-cyclohexylene and --A.sup.2 --[Z.sup.2 --A.sup.3 ].sub.n -- is ##STR1## and acid addition salts thereof, can be used as components of liquid crystal phases.
    • 式Ⅰ的含氮杂环化合物R1-A1-Z1-A2- [Z2-A3] n-R2其中R1和R2各自独立地为具有1-15个C原子的烷基,它也是 一个或两个不相邻的CH2基团可以被O原子和/或-CO-基团和/或-O-CO-基团和/或-CO-O-基团取代,并且基团R1和R2之一 也是H,F,Cl,Br或CN,A1是1,4-亚环己基,也可以将一个或两个不相邻的CH 2基团替换为O原子,1,4-二环 - ( 2,2,2) - 亚辛基或1,3-二噻烷-2,5-二基,Z1和Z2各自独立地为-CO-O-,-O-CO-,-CH2CH2- ,-OCH 2 - , - CH 2 O-或单键,A2和A3各自独立地为1,4-亚苯基,嘧啶-2,5-二基,1,4-亚环己基, 一个或两个不相邻的CH 2基团被O原子替代,1,3-二噻烷-2,5-二基或1,4-二环(2,2,2) - 亚辛基是可能的,n是 0 或1,条件是(a)基团A2和A3中的至少一个是嘧啶-2,5-二基,(b)如果A 2是,则Z1和Z 2中的至少一个不是单键 嘧啶-2,5-二基和R2是烷基或CN,(c)如果A3是嘧啶-2,5-二基,并且A1是1,4-亚环己基,则Z1不是-CO-O-,(d)n不是 如果A 1为1,4-亚环己基且Z 1为-CH 2 CH 2,则为0,(e)如果R 2为CN,则(Z1)不为-CH2CH2-,(f)Z1为-CH2CH2-,-OCH2-或-CH2O- A1是1,4-亚环己基,-A2- [Z2-A3] n-是它们的酸加成盐,可以用作液晶相的成分。
    • 75. 发明授权
    • Bicyclooctane derivatives
    • 双环辛烷衍生物
    • US4707295A
    • 1987-11-17
    • US843407
    • 1986-03-24
    • Ludwig PohlBernhard ScheubleAndreas WachtlerReinhard HittichPeter Fuss
    • Ludwig PohlBernhard ScheubleAndreas WachtlerReinhard HittichPeter Fuss
    • C07C1/00C07C13/44C07C17/00C07C23/10C07C23/20C07C41/00C07C43/115C07C43/18C07C45/00C07C47/34C07C49/115C07C67/00C07C69/608C07C253/00C07C255/45C07C255/46C07C313/00C07C317/10C07C317/18C07C317/20C07C317/24C07C317/44C07C317/46C07C323/06C09K19/30C09K19/32C09K19/44C09K19/46C09K19/54G02F1/13C07C23/32C07C69/753C07C121/46
    • C07C255/00C07C13/44C07C23/20C09K19/321
    • Bicyclooctane derivatives of the formula IR.sup.1 --A.sup.1 --A.sup.2 --R.sup.2 IwhereinR.sup.1 and R.sup.2 independently of one another are each an alkyl group which has 1-12 C atoms and in which it is also possible for one or two non-adjacent CH.sub.2 groups to be replaced by O atoms and/or CO groups and/or --O13 CO groups and/or --CO--O groups and/or --CH.dbd.CH-- groups, one of the radicals R.sup.1 and R.sup.2 being also --A.sup.3 --R.sup.3,A.sup.1 is a 1,4-cyclohexylene group which is unsubstituted or substituted in the 1-position and/or 2-position and/or 3-position and/or 4-position by alkyl which has in each case 1-5 C atoms and is unsubstituted or substituted or fluorinated, and in which it is also possible for one or two non-adjacent CH.sub.2 groups to be replaced by one or two different groupings from the group --O--, --CO--, --CH.dbd.CH--, --S--, --SO-- or --SO.sub.2 --, or is substituted by F, Cl, Br, CN and/or CHO,A.sup.2 is a 1,4-bicyclo[2.2.2] octylene group,--A.sup.3 --R.sup.3 is --Cy--R.sup.3, --Ph--R.sup.3, --Cy--Ph--R.sup.3 or --Ph--Cy--R.sup.3,Cy is 1,4-cyclohexylene or one of the other groups recited for A.sup.1,Ph is 1,4-phenylene which is unsubstituted or substituted by or one two F atoms and/or CH.sub.3 groups andR.sup.3 is an alkyl group which has 1-12 C atoms and in which it is also possible for one or two non-adjacent CH.sub.2 groups to be replaced by O atoms and/or CO groups and/or O--CO groups and/or --CO--O groups and/or --CH.dbd.CH-- groupsare suitable for use as components of liquid-crystal phases for field effect and/or bistability effect displys.
    • 式I R1-A1-A2-R2 I的双环辛烷衍生物,其中R 1和R 2彼此独立地是具有1-12个C原子的烷基,并且其中一个或两个不相邻的CH 2基团也是可能的 被O原子和/或CO基团和/或-O13CO基团和/或-CO-O基团和/或-CH = CH-基团取代,基团R1和R2之一也是-A3-R3, A1是未取代的或在1位和/或2位和/或3位和/或4位上被烷基取代的1,4-亚环己基,其各自为1-5个C原子和 是未取代或取代或氟化的,并且其中一个或两个不相邻的CH 2基团也可以被-O - , - CO - , - CH = CH - , - S,-SO-或-SO 2 - ,或被F,Cl,Br,CN和/或CHO取代,A2是1,4-双环[2.2.2]亚辛基,-A3-R3是-Cy -R3,-Ph-R3,-Cy-Ph-R3或-Ph-Cy-R3,Cy为1,4-亚环己基或为A1所列举的其它基团之一, Ph是未被取代或被两个F原子和/或CH 3基团取代的1,4-亚苯基,R 3是具有1-12个C原子的烷基,并且其中也可以有一个或两个不相邻的 被O原子和/或CO基团和/或O-CO基团和/或-CO-O基团和/或-CH = CH-基团取代的CH 2基团适用于现场的液晶相的组分 效果和/或双稳性效应不好。
    • 76. 发明授权
    • Optically active compounds, and a liquid-crystalline phase
    • 光学活性化合物和液晶相
    • US5393459A
    • 1995-02-28
    • US956938
    • 1992-10-05
    • Andreas WachtlerThomas GeelhaarReinhard HittichEkkehard BartmannJoachim KrauseEike Poetsch
    • Andreas WachtlerThomas GeelhaarReinhard HittichEkkehard BartmannJoachim KrauseEike Poetsch
    • C07C43/225C07C255/46C07D213/30C07D213/50C07D239/26C07D239/34C07D285/12C09K19/30C09K19/34C09K19/58C09K19/12G09F1/13
    • C07D213/30C07C255/46C07C43/225C07D213/50C07D239/26C07D239/34C07D285/12C09K19/3001C09K19/3444C09K19/3463C09K19/3497C09K19/588C07C2101/14
    • The invention relates to optically active compounds of the formula I ##STR1## in which R is an alkyl or alkenyl radical having up to 15 carbon atoms which is unsubstituted, monosubstituted by --CN or at least monosubstituted by fluorine or chlorine, it also being possible for a CH.sub.2 group in these radicals to be replaced by --O--, --CO--, --O--CO--, --CO--O-- or --O--CO--O--,A.sup.1 and A.sup.2 are each, independently of one another, a 1,4-phenylene radical, pyridine-2,5-diyl radical, pyrimidine-2,5-diyl radical, pyrazine-2,5-diyl radical, pyridazine-3,6-diyl radical, 1,3,4-thiadiazole-2,5-diyl radical, 1,2,4-thiadiazole-3,5-diyl radical or trans-1,4-cyclohexylene radical, each of which is unsubstituted or substituted by one or two fluorine atoms, and in which, in addition, one or two non-adjacent CH.sub.2 groups may be replaced by --O-- and/or --S--, and/or a CH group,Z.sup.1, Z.sup.2 and Z.sup.3 are each, independently of one another, --CO--O--, --O--CO--, --CH.sub.2 O--, --OCH.sub.2 --, --CH.sub.2 CH.sub.2 --, --CH.dbd.CH--, --C.tbd.C-- or a single bond,Q.sup.1 is --CH.sub.2 CH.sub.2 --, --CH.sub.2 CH.sub.2 CH.sub.2 --, --OCH.sub.2 --, --CH.sub.2 OCH.sub.2 --, --OCH.sub.2 CH.sub.2 --, --O--CO-- or --CO--OCH.sub.2 --,Q.sup.2 is --O--, --O--CO--, --(CH.sub.2).sub.3 --)-- or a single bond,m is 0, 1, 2 or 3,n is 0 or 1, ando is 1 to 9, and the use thereof as components of liquid-crystalline phases.
    • 本发明涉及式I的旋光活性化合物,其中R是具有至多15个碳原子的烷基或烯基,其未被取代,被-CN单取代或至少被氟或氯单取代,也可能是 对于这些基团中的CH 2基团被-O-,-CO-,-O-CO-,-CO-O-或-O-CO-O-,A1和A2各自彼此独立地取代, 吡啶-2,5-二基,嘧啶-2,5-二基,吡嗪-2,5-二基,哒嗪-3,6-二基,1,3,4-三基, 噻二唑-2,5-二基,1,2,4-噻二唑-3,5-二基或反-1,4-亚环己基,其各自为未取代的或被一个或两个氟原子取代,其中 另外,一个或两个不相邻的CH 2基团可以被-O-和/或-S-代替,和/或CH基,Z 1,Z 2和Z 3彼此独立地是-CO-O - , - O - CO - , - CH 2 O - , - OCH 2 - , - CH 2 CH 2 - , - CH = CH - , - C 3BOND C-或单键,Q 1是-CH 2 CH 2 - CH 2 CH 2 CH 2 - , - OCH 2 - , - CH 2 OCH 2 - , - OCH 2 CH 2 - , - O-CO-或-CO-OCH 2 - ,Q 2是-O - , - O - CO - , - (CH 2)3 - ) - 键,m为0,1,2或3,n为0或1,o为1至9,并且其用作液晶相的组分。
    • 80. 发明授权
    • Nitrogen-containing hetercyclic compounds
    • 含氮杂环化合物
    • US4882082A
    • 1989-11-21
    • US172424
    • 1988-03-23
    • Rudolf EidenschinkJoachim KrauseReinhard HittichEike PoetschBernhard ScheubleGeorg WeberLudwig Pohl
    • Rudolf EidenschinkJoachim KrauseReinhard HittichEike PoetschBernhard ScheubleGeorg WeberLudwig Pohl
    • C07D239/26C07D239/28C07D239/30C07D239/34C07D239/54C09K19/34C09K19/46G02F1/13
    • C07D239/26C07D239/34C09K19/3441
    • Nitrogen-containing heterocyclic compounds of the formula IR.sup.1 --A.sup.1 --Z.sup.1 --A.sup.2 [Z.sup.2 --A.sup.3 ].sub.n --R.sup.2whereinR.sup.1 and R.sup.2 in each case independently of one another are an alkyl group with 1-15 C atoms, it also being possible for one or two non-adjacent CH.sub.2 groups to be replaced by 0 atoms and/or --CO-- groups and/or --O--CO-- groups and/or --CO--O-- groups, and one of the radicals R.sup.1 and R.sup.2 is also H, F, Cl, Br or CN,is a 1,4-cyclohexylene group, it also being possible for one or two non-adjacent CH.sub.2 groups to be replaced by 0 atoms, a 1,4-bicyclo(2,2,2)-octylene group or a 1,3-dithiane-2,5-diyl group,Z.sup.1 and Z.sup.2 in each case independently of one another are --CO--O--, --O--CO--, --CH.sub.2 CH.sub.2 --, --OCH.sub.2 --, --CH.sub.2 O-- or a single bond,A.sup.2 and A.sup.3 in each case independently of one another are a 1,4-phenylene group, pyrimidine-2,5-diyl group, 1,4-cyclohexylene group, it also being possible for one or two non-adjacent CH.sub.2 groups to be replaced by 0 atoms, 1,3-dithiane-2,5-diyl group or a 1,4-bic)cloy2,2,2)-octylene group andis 0 or 1,with the provisos that(a) at least one of the groups A.sup.2 and A.sup.3 is a pyrimidine-2,5-diyl group,(b) at least one of the groups Z.sup.1 and Z.sup.2 is not a single bond if A.sup.2 is pyrimidine-2,5-diyl and R.sup.2 is alkyl or CN,(c) Z.sup.1 is not --CO--O-- if A.sup.3 is pyrimidine-2,5-diyl and A.sup.1 is 1,4-cyclohexylene,(d) n is not 0 if A.sup.1 is 1,4-cyclohexylene and Z.sup.1 is --CH.sub.2 CH.sub.2 --, and(e) Z.sup.1 is not --CH.sub.2 CH.sub.2 -- if R.sup.2 is CN, and(f) Z.sup.1 is --CH.sub.2 CH.sub.2 --, --OCH.sub.2 -- or --CH.sub.2 O--, if A.sup.1 is 1,4-cyclohexylene and --A.sup.2 --[Z.sup.2 --A.sup.3 ].sub.n --is ##STR1## and acid addition salts thereof, can be used as components of liquid crystal phases.
    • 式I R1-A1-Z1-A2 [Z2-A3] n-R2的氮杂环化合物,其中R1和R2各自独立地为具有1-15个C原子的烷基,也可能 一个或两个不相邻的CH2基团被0个原子和/或-CO-基团和/或-O-CO-基团和/或-CO-O-基团取代,基团R1和R2之一是 H,F,Cl,Br或CN也是1,4-亚环己基,也可以将一个或两个不相邻的CH 2基团替换为0个原子,1,4-二环(2,2 ,2) - 亚辛基或1,3-二噻烷-2,5-二基,Z1和Z2各自独立地为-CO-O-,-O-CO-,-CH2CH2-,-OCH2 - , - CH 2 O-或单键,A2和A3各自独立地为1,4-亚苯基,嘧啶-2,5-二基,1,4-亚环己基,也可以 一个或两个不相邻的CH2基团被0个原子替代,1,3-二噻烷-2,5-二基或1,4-bic)二(2,2,2) - 亚辛基,为0或1, w 条件是(a)A2和A3中的至少一个是嘧啶-2,5-二基,(b)如果A2是嘧啶-2,则基团Z1和Z2中的至少一个不是单键 ,5-二基和R 2是烷基或CN,(c)如果A3是嘧啶-2,5-二基,且A1是1,4-亚环己基,则Z1不是-CO-O-,(d)如果A1不是0,则n不为0 是1,4-亚环己基,Z 1是-CH 2 CH 2 - ,(e)如果R 2是CN,则Z 1不是-CH 2 CH 2 - ,(f)如果A 1是1,则Z 1是-CH 2 CH 2 - , - OCH 2 - 或-CH 2 O- ,4-亚环己基和-A2- [Z2-A3] n - ,其酸加成盐可用作液晶相的成分。